RLF
Relief Hldg
Stock
Stock
ISIN: CH1251125998
Ticker: RLF
CH1251125998
RLF
Price
Price
CHART BY
Frequently asked questions
What is Relief Hldg's market capitalization?
The market capitalization of Relief Hldg is $56.91M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Relief Hldg?
Relief Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.847. EPS indicates the company's profitability on a per-share basis.
What is Relief Hldg's revenue over the trailing twelve months?
Over the trailing twelve months, Relief Hldg reported a revenue of $8.96M.
What is the EBITDA for Relief Hldg?
Relief Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$9.66M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Relief Hldg?
Relief Hldg has a free cash flow of -$10.66M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Relief Hldg's shares?
The free float of Relief Hldg is 8.26M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $56.91M
- EPS (TTM)
- -$3.847
- Free Float
- 8.26M
- Revenue (TTM)
- $8.96M
- EBITDA (TTM)
- -$9.66M
- Free Cashflow (TTM)
- -$10.66M
Pricing
- 52W span
- $1.234$8.63
Information
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- CH1251125998
- Primary Ticker
- RLF